From topical research: Most commonly reported observation: mild transient redness at application site (attributed to vascular activity from VEGF stimulation) No systemic adverse events reported in human topical studies at standard concentrations No evidence of carcinogenicity or mutagenicity in available in vitro models From injectable research (preclinical): At supratherapeutic doses in animal models, mild injection site reactions have been noted No organ toxicity observed in standard preclinical safety panels No immunogenicity concerns identified (consistent with its endogenous structure) Copper considerations: GHK-Cu delivers a small amount of bioavailable copper
For general wellness maintenance, monthly glutathione as part of a comprehensive IV (Myers, Mega Myers) is common
Each method has its unique set of benefits, driven by factors such as bioavailability, convenience, cost, and personal health goals
One injection every three months is not sufficient for people with pernicious anemia
Immune system support: Glutathione plays an important role in supporting immune system function
Muscle recovery and protection: Prevents muscle damage during exercise and supports faster recovery